Abstract
Many studies suggest that insulin resistance develops and/or is maintained by an increased flux of glucose through the hexosamine biosynthesis pathway. This pathway may attenuate insulin-stimulated glucose uptake by activating protein kinase C (PKC). Therefore, we investigated whether the concentrations of the major hexosamine metabolites, uridine diphosphate-N-acetyl-glucosamine (UDP-GlcNAc) and uridine diphosphate-N-acetyl-galactosamine (UDP-GalNAc), and the expression levels of PKC isoforms were affected in Zucker Diabetic Fatty (ZDF) rats, an animal model widely used to study type 2 diabetes mellitus. At the age of 6 wk, control and ZDF rats were normoglycemic. Whereas control rats remained normoglycemic, the ZDF rats became hyperglycemic. The amount of UDP-GlcNAc and UDP-GalNAc in muscle tissue of ZDF rats was similar at 6, 12, 18, and 24 wk of age. Moreover, the concentration of both hexosamines did not differ among ZDF, phlorizin-treated ZDF, and control rats. Western blot analysis revealed that PKCα, δ, ɛ, and ζ, but not PKCβ and γ, were expressed in muscle and fat tissues from 6- and 24-wk-old control and ZDF rats. In addition, we did not observe changes in the expression levels of the PKC isoforms following prolonged hyperglycemia. Taken together, these findings indicate that the amounts of several metabolites from the hexosamine biosynthesis pathway and PKC isoforms, both hypothesized to be important in the development and/or maintenance of the insulin-resistant state of muscle and fat tissue, are not different in ZDF compared with nondiabetic rats.
Similar content being viewed by others
References
Gerich, J. E. (1988). Endocr. Rev. 19, 491–503.
Lebovitz, H. E. (1999). Clin. Chem. 45, 1339–1345.
Hussain, M. A. (1998). Eur. J. Endocrinol. 139, 472–475.
McClain, D. A. and Crook, E. D. (1996). Diabetes 45, 1003–1009.
Rossetti, L. (2000). Endocrinology 141, 1922–1925.
Marshall, S., Bacote, V., and Traxinger, R. R. (1991). J. Biol. Chem. 266, 4706–4712.
Ciaraldi, T. P., Carter, L., Nikoulina, S., Mudaliar, S., McClain, D. A., and Henry, R. R. (1999). Endocrinology 140, 3971–3980.
Hawkins, M., Barzilai, N., Chen, W., et al. (1996). Diabetes 45, 1734–1743.
Hawkins, M., Hu, M., Yu, J., et al. (1999). J. Biol. Chem. 274, 31312–31319.
Patti, M.-E., Virkamäki, A., Landaker, E. J., Kahn, R., and Yki-Järvinen, H. (1999). Diabetes 48, 1562–1571.
Robinson, K. A., Sens, D. A., and Buse, M. G. (1993). Diabetes 42, 1333–1346.
Virkamäki, A., Daniels, M. C., Hämäläinen, S., Utriainen, T., McClain, D., and Yki-Järvinen, H. (1997). Endocrinology 138, 2501–2507.
McKnight, G. L., Mudri, S. L., Mathews, S. L., et al. (1992). J. Biol. Chem. 267, 25208–25212.
Cooksey, R. C., Hebert, L. F., Zhu, J.-H., Wofford, P., Garvey, W. T., and McClain, D. A. (1998). Endocrinology 140, 1151–1157.
Hebert, L. F., Daniels, M. C., Zhou, J., et al. (1996). J. Clin. Invest. 98, 930–936.
Baron, A. D., Zhu, J. S., Zhu, J. H., Weldon, H., Maianu, L., and Garvey, W. T. (1995). J. Clin. Invest. 96, 2792–2801.
Heart, E., Chol, W. S., and Sung, C. K. (2000). Am. J. Physiol. Endocrinol. Metab. 278, E103-E112.
Hawkins, M., Angelov, I., Liu, R., Barzilai, N., and Rossetti, L. (1997). J. Biol. Chem. 272, 4889–4895.
Fillipis, A., Clark, S., and Proietto, J. (1997). Biochem. J. 324, 981–985.
Hofmann, J. (1997). FASEB J. 11, 649–669.
Jaken, S. (1996). Curr. Opin. Cell Biol. 8, 168–173.
Nishizuka, Y. (1995). FASEB J. 9, 484–496.
Cooper, D. R., Watson, J. E., and Dao, M. L. (1993). Endocrinology 133, 2241–2247.
Qu, X., Seale, J. P., and Donnelly, R. (1999). J. Endocrinol. 162, 207–214.
Avignon, A., Yamada, K., Zhou, X., et al. (1996). Diabetes 45, 1396–1404.
Clark, J. B., Palmer, C. J., and Shaw, W. N. (1983). Proc. Soc. Exp. Biol. Med. 173, 68–75.
Janssen, S. W., Martens, G. J., Sweep, C. G., Ross, H. A., and Hermus, A. R. (1999). Horm. Metab. Res. 31, 610–615.
Kanoh, Y., Bandyopadhyay, G., Sajan, M. P., Standaert, M. L., and Farese, R. V. (2000). J. Biol. Chem. 275, 16990–16996.
Nerlich, G. A., Sauer, U., Kolm-Litty, V., Wagner, E., Koch, M., and Schleicher, E. D. (1998). Diabetes 47, 170–178.
Schleicher, E. D. and Weigert, C. (2000). Kidney 58, S13-S18.
Yki-Järvinen, H., Daniels, M. C., Virkamäki, A., Mäkimattila, S., DeFronzo, R. A., and McClain, D. A. (1996). Diabetes 45, 302–307.
Robinson, K. A., Weinstein, M. L., Lindenmayer, G. E., and Buse, M. G. (1995). Diabetes 44, 1438–1446.
Nelson, B. A., Robinson, K. A., and Buse, M. G. (2000). Diabetes 49, 981–991.
McClain, D. A., Lubas, W. A., Cooksey, R. C., et al. (2002). Proc. Natl. Acad. Sci. USA 99, 10695–10699.
Vosseller, K., Wells, L., Lane, M. D., and Hart, G. W. (2002). Proc. Natl. Acad. Sci. USA 99, 5313–5318.
Nishizuka, Y. (1992). Science 258, 607–614.
Considine, R. V., Nyce, M. R., Allen, L. E., et al. (1995). J. Clin. Invest. 95, 2938–2944.
Armstrong, R.B. and Phelps, R.O. (1994). Am. J. Anat. 171, 259–272.
Span, P. N., Pouwels, M. J., Olthaar, A., Bosch, R. R., Hermus, A. R., and Sweep, C. G. (2001). Clin. Chem. 47, 944,945.
Smeets, R. L., Garner, K. M., Hendriks, M., et al. (1996). Cell Calcium 20, 1–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bosch, R.R., Janssen, S.W.J., Span, P.N. et al. Exploring levels of hexosamine biosynthesis pathway intermediates and protein kinase C isoforms in muscle and fat tissue of zucker diabetic fatty rats. Endocr 20, 247–252 (2003). https://doi.org/10.1385/ENDO:20:3:247
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:20:3:247